Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_assertion type Assertion NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_head.
- NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_assertion description "[Matrix metalloproteinase-9 (MMP-9) expression, related to blood-brain barrier disruption, has been implicated in the appearance of hemorrhagic transformation (HT) after tissue plasminogen activator (tPA) treatment in stroke patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_provenance.
- NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_assertion evidence source_evidence_literature NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_provenance.
- NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_assertion SIO_000772 14605329 NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_provenance.
- NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_assertion wasDerivedFrom befree-2016 NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_provenance.
- NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_assertion wasGeneratedBy ECO_0000203 NP419755.RASbn6friP3p4uGwndfW92FcuvhiTEK9buFekdeEfrhOQ130_provenance.